First Command Advisory Services’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-90
Closed -$2.93K 1313
2026
Q1
$2.93K Buy
+90
New +$2.89K ﹤0.01% 857

Other funds holding VKTX

First Command Advisory Services's VKTX Position: Q2 2026 in Review

First Command Advisory Services sold out of Viking Therapeutics (VKTX) in Q2 2026, closing a stake of 90 shares — an estimated $2.93K sold.

First Command Advisory Services first reported a position in VKTX in Q1 2026 and held it in 1 quarter. The position peaked at $2.93K in Q1 2026. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • First Command Advisory Services reported no remaining Viking Therapeutics position as of Q2 2026 after selling out during the quarter.
  • First Command Advisory Services sold 90 Viking Therapeutics shares in Q2 2026, an estimated $2.93K.
  • First Command Advisory Services first reported a position in Viking Therapeutics in Q1 2026 and held it in 1 quarter.
  • First Command Advisory Services's Viking Therapeutics position peaked at $2.93K in Q1 2026.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.